Cancer Therapy News and Research

RSS

Researchers reveal new vulnerability in MYC-driven lymphomas

Walter and Eliza Hall Institute researchers have revealed a new vulnerability in lymphomas that are driven by one of the most common cancer-causing changes in cells.

20 Feb 2020

Global study shows long-term survival benefit for a subset of patients with advanced lung cancer

According to the results of a large, global study led by Yale Cancer Center researchers, even a tiny amount of a biomarker known as PD-L1 (programmed death-ligand1) can predict a long-term survival benefit from using pembrolizumab (Keytruda).

20 Feb 2020

Researchers identify a protein that aids in colorectal cancer metastasis

A protein that helps colorectal cancer cells spread to other parts of the body could be an effective treatment target.

20 Feb 2020

Scientists discover novel molecular pathway involved in immunotherapy response

Scientists at The Wistar Institute discovered a novel pathway that enables detection of DNA in the cytoplasm and triggers inflammation and cellular senescence.

20 Feb 2020

MILabs achieves breakthrough in preclinical oncology imaging by eliminating positron range blurring effect

Researchers at MILabs B.V. have succeeded at imaging the popular Zirconium-89 isotope in small animals of human disease at very high resolutions (<0.75 mm).

19 Feb 2020

Study uncovers factors linked with discontinuing breast cancer therapy

For women with hormone receptor-positive breast cancer, long-term endocrine therapy can greatly reduce the risk of recurrence. Many women, especially those in underserved populations, do not continue treatment, however.

19 Feb 2020

Study provides insight into link between cancer driver gene and alternative splicing changes

A multi-institutional group of researchers led by Children's Hospital of Philadelphia has linked a strong cancer driver gene to changes in proteins that regulate alternative splicing.

17 Feb 2020

Targeting regulatory T cells could boost the effects of cancer immunotherapy

A Ludwig Cancer Research study has identified a mechanism by which regulatory T cells, which suppress immune responses, adapt their metabolism to thrive in the harsh microenvironment of the tumor.

17 Feb 2020

Bile duct cancer treatment could be improved by tailored medication

Treatment of patients suffering from bile duct cancer could be improved by tailoring medication to the levels of a key protein in people with the disease, according to new research.

16 Feb 2020

Thoracic radiation therapy can have negative impact on cancer patients' quality of life

Radiation doses to the heart that occur during radiation therapy treatments for lung cancer, breast cancer and lymphoma can increase fatigue, cause difficulty breathing and lower capacity for physical activity in patients with cancer, according to research presented at the American College of Cardiology's Advancing the Cardiovascular Care of the Oncology Patient course.

14 Feb 2020

Universal 'One-Size-Fits-All' Cancer Treatment

Andrew Sewell speaks to News-Medical about his breakthrough research, in which he has discovered a new T-Cell that could treat most cancers.

14 Feb 2020

UK cancer patients use Brainlab Mixed Reality Viewer to visualize, understand their treatment

For the first time, patients in the UK will have access to Brainlab Mixed Reality Viewer as part of their cancer treatment; a new way for physicians to provide visualization of treatment to their patients, actively involving them in their own cancer care.

13 Feb 2020

Researchers engineer probiotics to safely deliver immunotherapies to tumors

Researchers at Columbia Engineering have engineered probiotics to safely deliver immunotherapies within tumors.

12 Feb 2020

Study provides new details about therapy-associated polyposis in childhood cancer survivors

In a paper published online today, Dana-Farber Cancer Institute researchers provide new details about a recently discovered condition in which childhood cancer survivors develop numerous colorectal growths called polyps despite not having a hereditary susceptibility to the condition.

12 Feb 2020

Natural product from a fungus could shed light on cellular interactions prominent in cancer

A fungus that attacks almond and peach trees may be key to identifying new drug targets for cancer therapy.

12 Feb 2020

KAIST researchers identify mechanism that fuels a 'domino effect' in cancer drug resistance

KAIST researchers have identified mechanisms that relay prior acquired resistance to the first-line chemotherapy to the second-line targeted therapy, fueling a "domino effect" in cancer drug resistance.

11 Feb 2020

New summary report highlights advances and challenges in small cell lung cancer research

In 2017, a group of lung cancer experts posed the question: "Can recent advances in tumor biology that have led to progress treating non-small cell lung cancer translate into improved outcomes for small cell lung cancer?"

10 Feb 2020

Study: Most men choosing surgery for prostate cancer do not regret their decisions

Men with localized prostate cancer are faced with deciding among a range of options for treatment - including a choice between robot-assisted versus conventional prostatectomy.

10 Feb 2020

CRISPR-edited immune cells can be safely given to cancer patients

The emergence of CRISPR-Cas9 gene-editing technology has spurred hope in both doctors and patients since it shows promise in treating a multitude of diseases, including cancer. For the first time in the United States, a team of scientists has shown that CRISPR-edited immune cells can be safely used to cancer patients.

9 Feb 2020

Powerful vaccine could boost the effectiveness of cancer immunotherapy

Supercharging the mutation rate in cancer cells can create a powerful vaccine that is able to boost the effectiveness of immunotherapy, a major new study reports.

9 Feb 2020

Cancer Therapy News and Research

Researchers reveal new vulnerability in MYC-driven lymphomas

Global study shows long-term survival benefit for a subset of patients with advanced lung cancer

Researchers identify a protein that aids in colorectal cancer metastasis

Scientists discover novel molecular pathway involved in immunotherapy response

MILabs achieves breakthrough in preclinical oncology imaging by eliminating positron range blurring effect

Study uncovers factors linked with discontinuing breast cancer therapy

Study provides insight into link between cancer driver gene and alternative splicing changes

Targeting regulatory T cells could boost the effects of cancer immunotherapy

Bile duct cancer treatment could be improved by tailored medication

Thoracic radiation therapy can have negative impact on cancer patients' quality of life

Universal 'One-Size-Fits-All' Cancer Treatment

UK cancer patients use Brainlab Mixed Reality Viewer to visualize, understand their treatment

Researchers engineer probiotics to safely deliver immunotherapies to tumors

Study provides new details about therapy-associated polyposis in childhood cancer survivors

Natural product from a fungus could shed light on cellular interactions prominent in cancer

KAIST researchers identify mechanism that fuels a 'domino effect' in cancer drug resistance

New summary report highlights advances and challenges in small cell lung cancer research

Study: Most men choosing surgery for prostate cancer do not regret their decisions

CRISPR-edited immune cells can be safely given to cancer patients

Powerful vaccine could boost the effectiveness of cancer immunotherapy

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News